Atlas Trials

Propylene Glycol-Free Melphalan HCl (EVOMELA®) in Combination With Fludarabine and Total Body Irradiation Based Reduced Intensity Conditioning for Haploidentical Transplantation

Clinical trial NCT03159702 · COMPLETED

Trial details

NCT number
NCT03159702
Sponsor
Medical College of Wisconsin
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Hematological MalignancyMultiple Myeloma
Start date
2017-12-08
Primary completion
2024-11-12
Enrollment
43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.